Daniel Estay is the Founder and CEO of SonoVascular, where they lead an early-stage medical technology company developing innovative solutions for endovascular treatments. Previously, they served as President at Verathon and held various leadership roles in business development, including Vice President at Abbott and Manager at Johnson & Johnson. Daniel is currently a Board Member at VQ Biomedical and a Mentor-in-Residence for Medical Technology at Duke University's Office for Translation & Commercialization. They hold a Master of Business Administration in International Business from the University of Miami Business School and a Bachelor of Science in Business Administration from Syracuse University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices